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ABSTRACT
etinal vascular occlusions are serious diseases 
and significant causes of blindness that include 
1Rvenous and arterial obstructions.  They are the 
second most common retinal vascular diseases 
2following diabetic retinopathy.  Retinal vein occlusion 
(RVO) manifests at a mean age of 65 years and is more 
common in men than women with prevalence in 
population based studies ranging from 5.2 to 16 per 
2,31000.  There are three types of RVO: (1) Branch Retinal 
Vein Occlusion (BRVO) which is divided further into 
major BRVO and macular BRVO; (2) Central Retinal 
Vein Occlusion (CRVO) which can either be ischemic or 
nonischemic; and (3) Hemicentral Retinal Vein 
Occlusion (HRVO) which involves only one half of the 
retina surface and like CRVO is divided into ischemic 
4and nonischemic types. Central retinal vein occlusion 
blocks all venous outflow, whereas BRVO may be 
occlusion of a first-order (hemispheric or quadrantic) 
or second-order (macular or twig) tributary. 
Hemicentral retinal vein occlusion involves blockage 
of one of two central retinal vein trunks within the optic 
nerve head, an anatomical variation found in only 20 
5per cent of the population.   Branch retinal vein 
occlusion is four to six times more common than CRVO 
5,6while HRVO is the least common.
Retinal vein occlusion is associated with a number of 
systemic and ocular risk factors. The systemic risk 
factors include hypertension, diabetes mellitus, 
hyperlipidaemia, systemic vasculitis (sarcoidosis, 
syphilis), haematologic neoplasia (polycythemia rubra 
vera, leukemia), hypercoagulable states such as protein 
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PREVALENCE, PATTERN AND RISK FACTORS FOR RETINAL VASCULAR 
OCCLUSIONS IN A TERTIARY HOSPITAL IN JOS, NIGERIA
INTRODUCTION
Retinal vascular occlusions are the second most common retinal vascular diseases following diabetic retinopathy. 
They are associated with several systemic and ocular pathologies and are significant causes of visual loss. 
OBJECTIVE
This study aims to determine the prevalence, pattern and risk factors for retinal vascular occlusions in a tertiary 
hospital in Jos, Nigeria.
METHODOLOGY
A retrospective review of all cases of retinal vascular occlusions seen in the eye clinic from January 2011 to December 
2014 was carried out. The patients were identified from the clinic register and their case folders retrieved. The 
following data were then extracted from the files; patients' age, sex, presenting visual acuity, presence of any systemic 
disorders and type of retinal vascular occlusion. Data analysis was done using Epi Info 7.
RESULTS
Three thousand eight hundred and twenty one new patients were seen during the study period and there were 52 
(1.36%) cases of retinal vascular occlusions. Only the case files of 44(84.6%) patients were available and were analysed. 
These were made up of 17 (39%) males and 27 (61%) females. These had a total of 46 retinal vascular occlusions made 
up of 37 (80.4%)retinal vein occlusions,8 (17.4%) central retinal artery occlusions and a case (2.2%) of combined 
central retinal artery and vein occlusion.  Hypertension and diabetes were the most common systemic risk factors 
while glaucoma was the most common ocular association.
CONCLUSION
Retinal vascular occlusions are uncommon in our centre butlead to severe visual loss and are associated with 
significant systemic pathologies.
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taken in some of the patients when a fundus camera 
(Opto angiocam ADS 1.3 FA by Opto Electronica S/A, 
Sao Paulo, Brazil) was installed in the clinic. However, 
none of the patients had Fundus Fluorescein 
Angiography (FFA) or  Optical  Coherence 
Tomography (OCT) as the facilities for these were not 
available in the clinic during the study period. Where a 
patient had a bilateral vascular occlusion or 2 separate 
occlusions in the same eye, they were recorded as 
separate events. Any complication in an eye with more 
than one vascular occlusion occurring at different times 
was however recorded once. Results of blood 
investigations such as full blood count and erythrocyte 
sedimentation rate, electrolytes and urea, serum lipid 
profile were also evaluated and any derangement 
recorded. All eyes with retinal vascular occlusions, 
including both acute and old cases were included in the 
study. Data analysis was done using Epi Info 7.1.5.0. 
Mean values were compared by Student's t-test and 
2 frequencies by the χ test. A p value of less than 0.05 was 
considered statistically significant. Ethical clearance 
for the study was obtained from the Ethics Committee 
of the hospital.
RESULTS
Three thousand eight hundred and twenty one new 
patients were seen during the study period and 52 
(1.36%) of these had retinal vascular occlusion. These 
comprised of 43 RVOs (82.6%), 8 RAOs (15.4%) and 1 
case of CRAO with an impending CRVO (2%). Of these, 
only the case files of 44(85%) patients were available 
and were analysed. These were made up of 17 (39%) 
males and 27 (61%) females giving a male:female ratio 
of 1:1.6. These had a total of 46 retinal vascular 
occlusions with one patient having bilateral disease 
and another having two separate venous occlusions in 
the same eye. These were recorded as separate events. 
These 46 cases were made up of 37 RVOs (80.4%), 8 
RAOs (17.4%) and 1 case of CRAO with an impending 
CRVO (2.2%).  The RVOs comprised of 22 (47.8%) 
CRVOs, 11 (24%) HRVOs and 4 (8.7%) BRVOs.  All the 
RAOs involved the central retinal artery and one 
patient had bilateral involvement. Figure 1 shows the 
sex distribution of the various retinal vascular 
occlusions. The age range of the patients was 20-85 
years with a mean of 53.5 years (SD ±16.5). The mean 
age for patients with RVO was 57 years and for patients 
with RAO 38 years. This difference was statistically 
significant with a p value of 0. Two (25%) of the patients 
with CRAO were 50 years and above while 25 (68%) of 
the patients with RVO were 50 years and above (Table 
21).This difference was statistically significant (χ =4.96, 
p value = 0.03).
Presenting VA ranged from no light perception to 6/18. 
It was less than 3/60 in 31 (54%) eyes and less than 6/60 
in 35 (76%) eyes (Table 2). Seventeen (46%) of the 37eyes 
S deficiency and antiphosp holipid syndrome, drug 
therapy (oral contraceptives, diuretics, and 
hypotensive drugs)and atherosclerotic associated 
diseases (ischemic heart disease, obesity, and cigarette 
3smoking).   Ocular risk factors include glaucoma, 
decreased ocular perfusion pressure and external globe 
compression from orbital neoplasms and endocrine 
3orbitopathy.
Retinal artery occlusion (RAO) represents an 
ophthalmologic emergency as delay in treatment may 
1result in permanent loss of vision. According to the 
involved vessels, RAO can be subdivided into several 
forms, including: Central Retinal Artery Occlusion 
(CRAO), Branch Retinal Artery Occlusion (BRAO), 
cilioretinal artery occlusion, CRAO sparing cilioretinal 
artery, ophthalmic artery occlusion and CRAO 
7associated with CRVO.  The two main forms however 
7are CRAO and BRAO. Central retinal artery occlusions 
account for 58% of acute RAOs and BRAOs for 
138%. The combined incidence of CRAO andBRAO lies 
between 0.5 and 1.5 per 1000 initial ophthalmic 
8outpatient visits. The mean age of patients with CRAO 
2and BRAO is 62 years and 58 years respectively. Retinal 
artery occlusions are most often caused by emboli and 
the most common risk factors are arterial hypertension, 
diabetes mellitus, valvular diseases of the heart, and 
2carotid artery stenosis or plaques.
The department commenced treatment for retinal 
diseases in May 2011 following the installation of a 
diode laser machine in the eye clinic and inJuly 2013 
started administering intravitreal bevacizumab 
(Avastin) injections. Retinal vascular occlusions have 
been observed as a common indication for both 
procedures. We therefore sought to determine the 
prevalence and pattern of retinal vascular occlusions 
seen in our eye clinic as well as the associated risk 
factors over a 4 year period from January 2011 to 
December 2014. 
METHODOLOGY
A retrospective study of retinal vascular occlusions 
seen in the eye clinic over a period of 4 years from 
January 2011 to December 2014 was carried out. The 
number of new patients seen during this period was 
determined from the eye clinic register and all the cases 
of retinal vascular occlusions identified and their case 
files retrieved. The following data were then extracted 
from the files; patients' age, sex, presenting visual 
acuity (VA), presence of any systemic disorders, type of 
retinal vascular occlusion and duration of follow up. 
Ocular co-morbidities and complications of vascular 
occlusion such as macular oedema, ocular 
Neovascularization (NV) and Neovascular Glaucoma 
(NVG) were all recorded. Fundus photographs were 
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of RVO seen in this study and this compares with other 
12,13studies in Nigeria.  Studies done in Asia and America 
however reported BRVO as the commonest type of 
9-11,15RVO seen.  This difference may be as a result of 
study design and ethnic differences. Also, CRVO 
12,15results in more profound visual loss  and this may 
make it more likely for patients with this condition to 
seek medical care in the hospital.  Retinal artery 
occlusion is a rare event with studies in America and 
Croatia estimating an annual incidence of 1.90 and 0.70 
17,19per 100,000 respectively. All the cases of RAO in this 
series were occlusions of the central retinal artery. A 
study on RAO in the young by Ratra and Dhupper also 
reported CRAO as the most common type of RAO seen 
20followed by BRAO. In contrast however, Greven et 
21al reported BRAO as the most common type of RAO 
seen in a study conducted in patients less than 40 years 
of age.
Retinal vascular occlusive disease is associated with 
advancing age and significant systemic and 
9,17ophthalmic pathologies. The mean age of patients 
with RVO in this study compares favourably with 54 
years and 58 years reported by other authors in 
12,13Nigeria  but is lower than findings in other studies 
done in Asia where mean ages of over 60 years were 
11,14reported.  For patients with CRAO however, the 
mean age obtained in this study contrasts sharply with 
the mean of 74yrs and 66yrs obtained in America and 
17,19Europe respectively. Racial differences as well as the 
relatively smaller number of cases in this series may 
explain this age differences.
S y s t e m i c  d i s e a s e s  s u c h  a s  h y p e r t e n s i o n ,  
hyperlipidaemia and diabetes are associated with the 
1 7 ,  2 2development  of  both  RVO and RAO.  
Hypertensionwasthe major systemic association in this 
study.  This is consistent with findings from previous 
12-17studies. Hypertension in blacks tends to be more 
severe and develops at an earlier age. The overall 
mortality due to hypertension and its consequences is 
23also more likely in blacks.  This may explain the lower 
mean age of patients with RVO in this series. 
Hypertension and diabetes, the major risk factors in 
this studyare associated with an increased risk of 
systemic arteriosclerosis, which is generally 
considered the main pathophysiological component of 
3developing RVO.
Central retinal artery occlusion is mostly due to 
atherosclerosis related thrombosis at the level of the 
24lamina cribrosa.  The incidence of atherosclerosis 
increases with age and is also accelerated by 
hypertension, diabetes, hyperlipidaemia, oral 
24contraceptives, and hyperhomocysteinaemia. The 
proportion of   patients with CRAO that had 
with RVO and 7 (88%) eyes with RAO had a VA of less 
than 3/60. This difference was not statistically 
2significant (χ =0.38, p value = 0.53)
The most common systemic association identified was 
hypertension followed by diabetesmellitus(Table 3). 
Hypertension was associated with 29(78%) eyes with 
RVOand 3 (38%) eyes with RAO. This difference was 
2 statistically significant (χ =5.35 p value = 0.02).Diabetes 
mellitus was associated with 10 (27%) eyes with RVO 
and 1(13%) eye with RAO.This difference was not 
2 statistically significant (χ = 0.73, p value = 0.39). 
Othersystemic disorders identified were 1 case each of 
alcoholic cardiomyopathy, sickle cell disease, 
thrombocytosis, hyperlipidaemia andHuman 
Immunodeficiency Virus (HIV) infection. The patient 
with HIV had bilateral CRAO.Glaucoma occurred in 8 
(22%)eyes with RVO and in 1 (13%) eye with RAO. This 
2difference was not statistically significant (χ = 0.5, p 
value = 0.47). The only other ocular association was a 
case of papillitis diagnosed in an eye with CRAO. 
Twenty two (48%) eyes were associated with more than 
one risk factor.
Ocular complications were documented in 32 (70%) 
eyes (Figure 2). These comprised of ocular NV; 13 
(28%),macular oedema; 12 (26%),NVG; 7 (15%) and 
vitreous haemorrhage; 1 (2%).Ocular NV wasseen in 12 
(32%) cases of RVO and one (13%) case of CRAO. This 
2difference was statistically significant (χ =4.22, p value 
= 0.03). These cases of RVO with NV comprised of 4 
HRVOs (1 iris NV,3 retinal NVs) and 8 CRVOs (5 iris 
NVs, 3 retinal NVs). Macular oedema was seen in 8 
(22%) eyes with RVO and 3 (38%) eyes with CRAO. 
2This difference was not statistically significant(χ = 0.9, 
p value = 0.34). Neovascular glaucoma was seen in 7 
(15%) eyes; 6 RVOs and 1 CRAO. This difference was 
2also not statistically significant (χ = 0.06, p value=0.8).  
The only eye with HRVO that developed NVG had 
features of an old superior HRVO and an acute inferior 
HRVOat presentation.
DISCUSSION
Retinal vascular occlusions are uncommon in our 
centre accounting for less than 2% of all new patients 
seen during the study period. The prevalence of RVO in 
this study lies between 0.6% and 2.1 % obtained in 
9-11population based studies in America and Asia.  A 
female preponderance was observed in this study. For 
patients with RVO this is in consonance with reports 
12,13from other tertiary institutions in Nigeria.  Other 
studies on RVO however observed no significant 
9,10,14-gender difference or a male preponderance.
16Studies on RAO reported a gender difference with 
17,18male predominace.
Central retinal vein occlusion was the commonest type 
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28-following CRAO and 15% to 18% for associated NVG.
30
Retinal vein occlusion is a very elegant example of a red 
(haemorrhagic) infarct, whereas RAO typifies a white 
31(ischaemic) infarct.  Regardless of mechanism, 
unresolved infarction results in tissue death and tissue 
5death leads to visual loss.  Majority of the patients in 
this series presented with poor vision with VA of less 
than 6/60.For the RVOs, most of those with poor visual 
acuities were eyes with CRVO. This is in keeping with 
12,15,16findings from other studies. Acute CRAO presents 
with a sudden, painless and profound drop in vision, 
usually with an initial Snellen acuity of counting 
fingers or worse, unless a cilioretinal artery is present in 
8,32which case central vision may be preserved. Only one 
eye with CRAO in this study had a VA greater than 
6/60. Thiseye may have had acilioretinal artery sparing 
not documented at the time the patient was seen. In a 
33study by Hayreh and Zimmerman  on the visual 
outcome in CRAO, 80% of the patients had profound 
visual loss with VA less than 3/60. This agrees with 
87.5% obtained in this study. 
The limitations of this study include its retrospective 
design and the relatively small number of cases 
reviewed. Also FFAas well as OCT were not available 
during the study period. FFA would have been 
valuable in differentiating ischaemic from non-
ischaemic RVO while OCT would have been helpful in 
evaluating the macular for the presence or absence of 
oedema.
 In conclusion our results indicate that retinal vascular 
occlusions are uncommon in our centre, result in severe 
visual loss and are most commonly associated with 
hypertension and diabetes mellitus. A comprehensive 
management of patients with retinal vascular 
occlusions is therefore necessary to correct associated 
diseases or predisposing risk factors that could lead to 
local recurrences. Early diagnosis and treatment of 
these associated systemic disorders in the general 
population will also help in reducing the incidence of 
these conditions and resultant blindness.
hypertension and diabetes in our series is lower than 
17what was reported by Leavitt et al.  Hypertension and 
diabetes are diseases of the older population and the 
mean age of patients with RAO in this study was 38 
years.
Glaucoma was the major ocular risk factor for vascular 
occlusion in this series. Studies have shown a 
15,25significant association between RVO and glaucoma.  
Twenty two percent of eyes with RVO in this series had 
associated glaucoma. This correlates with 22.2% 
13reported by Nwosu  but contrasts with 33.3% and 9.9% 
12 26reported by Feibai et al  and Hayreh et al  respectively.
The commonest ocular complication seen in this study 
wasocular NV. This is at variance with reports by Feibai 
12 16et al and Prajapati et al which reported vitreous 
haemorrhage and macular oedema respectively as the 
most common complication in their series. These 
differences could be as a result of variations in time 
intervals from the acute event to presentation in the 
hospital as well as duration of follow-up. In RVO, 
ocular NV is a complication of ischemic CRVO/HRVO 
and major BRVO only. It does not occur in non-
26 ischemic CRVO/HRVO or macular BRVO. This 
implies that the cases with this complication in this 
series were most likely the ischaemic types of RVO 
even though this was not confirmed by FFA. A study by 
27Hayreh and Zimmerman  showed that in ischemic 
CRVO, anterior segment NV is much more common 
than posterior segment NV while the reverse is the case 
with HRVO. This correlates with our finding in this 
series. The only eye with HRVO that developed 
anterior segment NV had occlusions of the superior 
and inferior hemiretinal vein occurring on separate 
occasions. The proportion of eyes with RVO that 
developed NVG in our study is slightly lower than 20% 
16reported by Prajapati et al. For the cases of CRAO the 
prevalence of ocular NV and NVG was 13% 
respectively. This is comparable to findings in other 
studies that reported a prevalence of 18% for iris NV 
TABLES AND FIGURES
Figure 1; Sex Distribution
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Table 3; Systemic and ocular associations
Type of VO        HT DM       HIV      SCD     Glaucoma     Others
n (%)        n (%)     n(%)     n(%)         n(%)            n(%) 
CRVO 17(53)        4(36.4)      -            -           3(33.3)         -
BRVO 4(13)      2(18.2)      -             -          3(33.3)         -
HRVO 8(25)      4(36.4)      -             -          2(22.2)        -
CRAO 3(9)        1(9)          2 (100)    -1(11.1)       6(100)  
CRAO+CRVO     -             -           -            1(100)     -               -
Total          32 (100)  11(100)   2(100)    1(100)    9(100)     6(100)
VO: Vascular Occlusion, HT: Hypertension, DM: Diabetes Mellitus, HIV: 
Human Immunodeficiency Virus, SCD: Sickle Cell Disease
Table 1; Age Specific Prevalence of Retinal Vascular 
Occlusions
Age (yrs)     CRVO       BRVO        HRVO          CRAO    CRAO+CRVO   Total
 n(%)          n(%)             n(%)            n(%)            n(%)                n(%)
20-29   -               1(25)1(9.1) 1(12.5) - 3(6.5)
30-39 1(5)      -  - 4 (50) -                   5 (11)
40-49 5(23)         -             4(36.4)1(12.5)1(100)                11(24)
50-59        4(18)        1(25) 3(27.3)1(12.5) -               9(19.5)
60-69        6(27)        1(25)3(27.3) 1(12.5)-        11(24)
70-79 2(9)          -                   -                -                  -                      2(4.4)
80-89        4(18)        1(25) -             -           -              5(11)
Total 22(100)     4(100) 11(100)8(100) 1(100)       46(100)
CRVO: Central Retinal Vein Occlusion, BRVO: Branch Retinal Vein 
Occlusion, HRVO: Hemiretinal Vein Occlusion, CRAO; Central Retinal 
Artery Occlusion
Table 2; Presenting Visual Acuity 
VA      CRVO      BRVO    HRVO    CRAO      CRAO+CRVO       Total
n (%)              n (%)  n (%)              n (%)            n(%)                n(%)
<3/60     14 (63.6)          -          3(27.3)         7(87.5)        1(100)           25 (54)
3/60 -<6/60         3 (13.6)         3 (75)              4(36.4)          -                 -      10 (22)
6/60-<6/18          4 (18.2)         1 (25)              2 (18.2)         1 (12.5)      -      8 (17)
≥ 6/18                 1 (4.5)            -                     2 (18.2)        -        - 3 (7)
Total      22 (100)           4 (100)            11 (100)       8 (100)         1 (100)     46(100)
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